Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
BioNTech SE

BioNTech SE (BNTX) Stock Overview

Explore BioNTech SE’s financial performance, market position, analyst ratings, and future outlook.

BNTX●NASDAQ
HealthcareBiotechnology
$91.00
$1.25(1.36%)
U.S. Market is Open · 14:24

BioNTech SE (BNTX)

Meyka AI Score

Z

Key Financials

Market Cap23.1B
P/E Ratio-15.59
EPS (TTM)$-4.62
ROE-0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$84.94
3 Months$94.02
1 Year Target$110.71

BNTX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of BioNTech SE (NASDAQ: BNTX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, BioNTech SE's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BNTX on the NASDAQ shows an RSI of 48.77, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $110.71 for the NASDAQ listing.

Key metrics behind BioNTech SE's NASDAQ-traded stock include a P/E ratio of -15.59 and a market capitalization of 23.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BNTX on the NASDAQ.

Price Performance (NASDAQ: BNTX)

1-Day Change
-0.98%
5-Day Change
-0.84%
1-Month Change
-2.75%
3-Month Change
-8.05%
6-Month Change
-16.02%
Year-to-Date (YTD) Change
-4.04%
1-Year Change
-16.98%
3-Year Change
-14.21%
5-Year Change
-77.96%
All-Time (Max) Change
541.50%

Contact Information

https://www.biontech.com/de/de/home.html
49 6131 9084 0
An der Goldgrube 12, Mainz, RP, 55131

Company Facts

78,070 Employees
IPO DateOct 10, 2019
CountryDE
Actively Trading

Frequently Asked Questions